Bipolar disorder

... blackenterprise.com Home email ALEXANDRIA, Va., March 22 /U.S.

Newswire/ - Following is a statement by Cynthia Wainscott, acting president and CEO of NMHA, on the FDA review of ADHD medications for youth: After a review of data regarding the safety of medication for Attention Deficit Hyperactivity Disorder (ADHD) in youth, the Food and Drug Administration convenes a hearing today to review the data and determine if additional regulatory actions - such as mandating stricter warnings on labels - are needed to promote their safe pediatric use.

The National Mental Health Association (NMHA) strongly advocates for more scientific research on the safety of all medications prescribed to children and commends the FDA for initiating this review.

Traditionally, very little research has been conducted on children and medications.

Yet there is no question that ADHD medications, like medications used to treat physical ...

Read more...